Business2 years ago
Buy this ‘game-changer’ biotech stock with more than 50% upside, BofA says
[ad_1] Neumora Therapeutics could transform the current neuroscience treatment landscape, according to Bank of America. The firm initiated coverage of the biotech company on Tuesday with...
